SEC Comment Letter for CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Feb 5, 2019
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: Feb. 5, 2019 · CIK: 0001175680 · Accession: 0000000000-19-001146
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228991
Letter
February 5, 2019 Michael Mulholland Chief Financial Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, WA 98660 Re:CytoDyn Inc. Registration Statement on Form S-3 Filed December 21, 2018 File No. 333-228991 Dear Mr. Mulholland: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dorrie Yale at 202-551-8776 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: James O'Grady
Show Raw Text
February 5, 2019
Michael Mulholland
Chief Financial Officer
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, WA 98660
Re:CytoDyn Inc.
Registration Statement on Form S-3
Filed December 21, 2018
File No. 333-228991
Dear Mr. Mulholland:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dorrie Yale at 202-551-8776 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: James O'Grady